BIOMAT Database Logo BIOMAT Database Logo

[Cryoglobulinemic nephritis associated with chronic HCV infection]. 2000

N A Mukhin, and L V Kozlovskaia, and E Iu Malyshko, and N B Gordovskaia, and V A Varshavskiĭ, and T M Ignatova

UI MeSH Term Description Entries
D009393 Nephritis Inflammation of any part of the KIDNEY. Nephritides
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003449 Cryoglobulinemia A condition characterized by the presence of abnormal quantities of CRYOGLOBULINS in the blood. Upon cold exposure, these abnormal proteins precipitate into the microvasculature leading to restricted blood flow in the exposed areas. Cryoglobulinemias
D003450 Cryoglobulins Abnormal immunoglobulins, especially IGG or IGM, that precipitate spontaneously when SERUM is cooled below 37 degrees Celsius. It is characteristic of CRYOGLOBULINEMIA. Cryoglobulin,Cryoprotein,Cryoproteins
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D018937 Hepatitis C Antibodies Antibodies to the HEPATITIS C ANTIGENS including antibodies to envelope, core, and non-structural proteins. Anti-HCV Antibodies,Anti-Hepatitis C Virus Antibodies,HCV Antibodies,Hepatitis C Virus Antibodies,Anti HCV Antibodies,Anti Hepatitis C Virus Antibodies
D019698 Hepatitis C, Chronic INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS. Chronic Hepatitis C

Related Publications

N A Mukhin, and L V Kozlovskaia, and E Iu Malyshko, and N B Gordovskaia, and V A Varshavskiĭ, and T M Ignatova
[HCV-associated cryoglobulinemic vasculitis].
January 2012, Terapevticheskii arkhiv,
N A Mukhin, and L V Kozlovskaia, and E Iu Malyshko, and N B Gordovskaia, and V A Varshavskiĭ, and T M Ignatova
[SEVERE HCV-ASSOCIATED CRYOGLOBULINEMIC VASCULITIS].
January 2015, Klinicheskaia meditsina,
N A Mukhin, and L V Kozlovskaia, and E Iu Malyshko, and N B Gordovskaia, and V A Varshavskiĭ, and T M Ignatova
[Treatment of HCV-associated cryoglobulinemic glomerulonephritis].
January 2009, Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia,
N A Mukhin, and L V Kozlovskaia, and E Iu Malyshko, and N B Gordovskaia, and V A Varshavskiĭ, and T M Ignatova
Relationship between cryoglobulinemia-associated nephritis and HCV infection.
July 2008, Expert review of clinical immunology,
N A Mukhin, and L V Kozlovskaia, and E Iu Malyshko, and N B Gordovskaia, and V A Varshavskiĭ, and T M Ignatova
Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection.
January 2018, Joint bone spine,
N A Mukhin, and L V Kozlovskaia, and E Iu Malyshko, and N B Gordovskaia, and V A Varshavskiĭ, and T M Ignatova
Lupus nephritis and HCV infection.
May 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
N A Mukhin, and L V Kozlovskaia, and E Iu Malyshko, and N B Gordovskaia, and V A Varshavskiĭ, and T M Ignatova
HCV and cryoglobulinemic vasculitis.
January 2002, Cleveland Clinic journal of medicine,
N A Mukhin, and L V Kozlovskaia, and E Iu Malyshko, and N B Gordovskaia, and V A Varshavskiĭ, and T M Ignatova
Hepatitis A Virus Infection Associated with Cryoglobulinemic Vasculitis.
January 2020, Indian pediatrics,
N A Mukhin, and L V Kozlovskaia, and E Iu Malyshko, and N B Gordovskaia, and V A Varshavskiĭ, and T M Ignatova
Interferon treatment for thrombocytopenia associated with chronic HCV infection.
December 2000, International journal of clinical practice,
N A Mukhin, and L V Kozlovskaia, and E Iu Malyshko, and N B Gordovskaia, and V A Varshavskiĭ, and T M Ignatova
[Steroids, interferon-alpha and ribavirin treatment of cryoglobulinemic glomerulonephritis concurrent with HCV infection].
January 2002, Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia,
Copied contents to your clipboard!